Risk factors for fibrosis progression in non-alcoholic steatohepatitis: Analysis of the European cohort in the real-world GAIN study Anum Shaikh; Gabriel Pedra; Leonardo Ruiz-Casas; Bethany Franks; Harpal Dhillon; João Diogo da Rocha Fernandes; Kamal Kant Mangla; Margarida Augusto; Manuel Romero-Gómez; Jörn M. Schattenberg;

Vinpocetine represses the progression of nonalcoholic steatohepatitis in mice by mediating inflammasome components via NF-¿B signaling Yingwei Zhu; Hong Tang; Han Zhao; Jian Lu; Kai Lin; Jingbin Ni; Bo Zhao; Gaojue Wu; Chunxiao Tan;

PROGRESSION OF FIB-4 INDEX PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH METABOLIC DYSFUNCTION Francisco Idalsoaga; Verónica Cambindo; Eduardo Fuentes-López; Eitan Dukes; Samuel Ibañez; Paola Hunfan; Constanza Mollo; Jorge Gonzalez; Gustavo Ayares; Carolina Ramirez-Cadiz; Francisco Barrera; Monica Acevedo; Patrick S. Kamath; Richard Sterling; Marco Arrese; Luis Antonio Díaz; Juan Pablo Arab;